Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00005860What this trial is testingOxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01534637What this trial is testingAprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic CancerWho this might be right forExtrahepatic Bile Duct CancerNauseaVomiting+3 more Wake Forest University Health Sciences 22
Testing effectiveness (Phase 2)Study completedNCT03044587What this trial is testingNal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract CancerWho this might be right forAdenocarcinoma MetastaticBiliary Tract CancerAdenocarcinoma of the Biliary Tract+4 more AIO-Studien-gGmbH 93
Testing effectiveness (Phase 2)Study completedNCT00033540What this trial is testingS0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or CholangiocarcinomaWho this might be right forExtrahepatic Bile Duct CancerGallbladder Cancer SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)Study completedNCT00084942What this trial is testingGemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the GallbladderWho this might be right forExtrahepatic Bile Duct CancerGallbladder Cancer Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00003557What this trial is testingDolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer University of Chicago 16
Large-scale testing (Phase 3)Study completedNCT00304135What this trial is testingFluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By SurgeryWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Federation Francophone de Cancerologie Digestive 34
Testing effectiveness (Phase 2)Study completedNCT00021047What this trial is testingEpirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorWho this might be right forEsophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00987766What this trial is testingGemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+3 more Vanderbilt-Ingram Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT00903396What this trial is testingPalonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Alliance for Clinical Trials in Oncology 7
Early research (Phase 1)Study completedNCT00010023What this trial is testingCapecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forCancer NYU Langone Health
Testing effectiveness (Phase 2)Ended earlyNCT01229111What this trial is testingCediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary CancersWho this might be right forAdult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+8 more National Cancer Institute (NCI) 14
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT01954745What this trial is testingCabozantinib (XL-184) Monotherapy for Advanced CholangiocarcinomaWho this might be right forBile Duct CancerIntrahepatic CholangiocarcinomaCholangiocarcinoma of the Extrahepatic Bile Duct Massachusetts General Hospital 19
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Large-scale testing (Phase 3)Study completedNCT00262769What this trial is testingGemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract TumorsWho this might be right forExtrahepatic Bile Duct CancerGallbladder Cancer University College, London 324
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Large-scale testing (Phase 3)Ended earlyNCT00658593What this trial is testingGemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer NCIC Clinical Trials Group 19